No Prescription |
 |
 | ||
|
Accuretic Accupril |
|
| ||
No Prescription » Prescription Drugs 1 » Accuretic Accupril Hypertension is characterised by abnormally high blood pressure.ACE Inhibitors: It acts by inhibiting angiotensin converting enzyme. This prevents the conversion of angiotensin I to Angiotensin II. It is effective in all types of hypertension.Diuretics potentiate the effect of Quinapril.Hypertension leads to serous problems includes stroke heart disease and kidney failure. Blood pressure needs to check on regular basis.Accuretic is combination of ACE inhibitor Quinapril and Diuretic Hydrochlorothiazide.Accuretic is used to lower high blood pressure.Accuretic widens blood vessels and reduces pressure is blood vessels. It helps heart to pump blood throughout the body. It helps kidneys to pass more water salt and retains potassium.Dosage: Admin before food preferably.For most patients the usual starting dose of ACCURETIC is 10/12.5 mg a day. The dose may need to be increased to one ACCURETIC 20/12.5 tablet a day then two ACCURETIC 10/12.5 tablets a day if necessary. Most patients take between 10/12.5 to 20/12.5 mg daily. Each dose may be taken once a day. Buy Accuretic Accupril and other Prescription Drugs 1 products online at Medstore. Buy Online at Medstore - Click Here!
About Accuretic Accupril: Product Type: Prescription Drugs 1 Accuretic ( Accupril Acuitel Generic Quinapril hydrochloride + Hydrochlorothiazide ) Accuretic (Accupril Acuitel Generic Quinapril hydrochloride + Hydrochlorothiazide) Accupril Acuitel Generic Quinapril hydrochloride + Hydrochlorothiazide 10/12.5mg 30 Tablets 10/12.5mg 3 x 30 Tablets 20/12.5mg 30 Tablets 20/12.5mg 3 x 30 Tablets Accupril Acuitel Generic Quinapril hydrochloride + Hydrochlorothiazide Accuretic
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
